Publication | Closed Access

Development and validation of a highly sensitive LC-ESI-MS/MS method for estimation of IIIM-MCD-211, a novel nitrofuranyl methyl piperazine derivative with potential activity against tuberculosis: Application to drug development

Potential ActivityMedicinal ChemistryDrug AnalysisPulmonary TuberculosisHealth SciencesPharmaceutical ScienceMedicineTuberculosisPharmacotherapyDrug DevelopmentPharmacologyRadiation OncologySensitive Lc-esi-ms/ms MethodDrug DiscoveryDrug Resistance